Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer
Tamara L. Lotan, Harsimar Kaur, Daniela C. Salles, Sanjana Murali, Edward M. Schaeffer, Jerry S. Lanchbury, William B. Isaacs, Robert Brown, Andrea L. Richardson, Olivier Cussenot, Géraldine Cancel‐Tassin, Kirsten M. Timms, Emmanuel S. Antonarakis
Topics & Concepts
Prostate cancerCHEK2Loss of heterozygosityOlaparibGermlineCohortGermline mutationMedicineOncologyInternal medicineProstateCancerCancer researchMutationAlleleBiologyGeneticsGenePoly ADP ribose polymerasePolymerasePARP inhibition in cancer therapyDNA Repair MechanismsProstate Cancer Treatment and Research